FDA Advisers Back Pfizer’s COVID-19 Vaccine For Young Kids Ages 5-11

U.S. health advisers have endorsed kid-size doses of Pfizer’s COVID-19 vaccine for younger children.

No Responses to “FDA Advisers Back Pfizer’s COVID-19 Vaccine For Young Kids Ages 5-11”

Post a Comment